R. T. Steigbigel, D. A. Cooper, and P. N. Kumar, Raltegravir with optimized background therapy for resistant HIV-1 infection, N Engl J Med, vol.359, issue.4, pp.339-354, 2008.

J. K. Rockstroh, E. Dejesus, and J. L. Lennox, Durable efficacy and safety of raltegravir versus efavirenz when combined with tenofovir/ emtricitabine in treatment-naive HIV-1-infected patients, J Acquir Immune Defic Syndr, vol.63, issue.1, pp.77-85, 2013.

T. Boulet, J. Pavie, and I. Charreau, Impact on health-related quality of life of a switch from enfuvirtide to raltegravir among multidrugresistant HIV-1-infected patients: a randomized open-label trial, HIV Clin Trials, vol.11, issue.5, pp.283-293, 2010.

C. Cohen, D. A. Revicki, A. Nabulsi, P. W. Sarocco, and P. Jiang, A randomized trial of the effect of ritonavir in maintaining quality of life in advanced HIV disease, AIDS, vol.12, issue.12, pp.1495-1502, 199820.

M. D. Nglazi, S. J. West, J. A. Dave, N. S. Levitt, and E. V. Lambert, Quality of life in individuals living with HIV/AIDS attending a public sector antiretroviral service in Cape Town, South Africa, BMC Public Health, vol.14, p.676, 2014.

P. T. Nieuwkerk, E. H. Gisolf, R. Colebunders, A. W. Wu, S. A. Danner et al., Quality of life in asymptomatic-and symptomatic HIV infected patients in a trial of ritonavir/saquinavir therapy. The Prometheus Study Group, AIDS, vol.14, issue.2, pp.181-187, 2000.

E. Jong, L. A. Oudhoff, and C. Epskamp, Predictors and treatment strategies of HIV-related fatigue in the combined antiretroviral therapy era, AIDS, vol.24, issue.10, pp.1387-1405, 2010.

A. Adinolfi, Assessment and treatment of HIV-related fatigue, J Assoc Nurses AIDS Care, vol.12, pp.29-34, 2001.
DOI : 10.1177/105532901773742266

J. Barroso, J. L. Harmon, J. L. Madison, and B. W. Pence, Intensity, chronicity, circumstances, and consequences of HIV-related fatigue: a longitudinal study, Clin Nurs Res, vol.23, issue.5, pp.514-528, 2014.

J. Barroso and J. G. Voss, Fatigue in HIV and AIDS: an analysis of evidence, J Assoc Nurses AIDS Care, vol.24, issue.1, pp.5-14, 2013.

L. Michel, V. Villes, and F. Dabis, Role of treatment for depressive symptoms in relieving the impact of fatigue in HIV-HCV co-infected patients: ANRS Co13 Hepavih, J Viral Hepat, vol.17, issue.9, pp.650-660, 2006.

F. Marcellin, M. Préau, I. Ravaux, P. Dellamonica, B. Spire et al., Self-reported fatigue and depressive symptoms as main indicators of the quality of life (QOL) of patients living with HIV and Hepatitis C: implications for clinical management and future research, HIV Clin Trials, vol.8, issue.5, pp.320-327, 2007.

C. Protopopescu, F. Marcellin, and B. Spire, Health-related quality of life in HIV-1-infected patients on HAART: a five-years longitudinal analysis accounting for dropout in the APROCO-COPILOTE cohort (ANRS CO-8) Qual Life Res, vol.16, pp.577-591, 2007.

B. Spire, F. Marcellin, and I. Cohen-codar, Effect of lopinavir/ ritonavir monotherapy on quality of life and self-reported symptoms among antiretroviral-naive patients: results of the MONARK trial, Antivir Ther, vol.13, issue.4, pp.591-599, 2008.

P. Pugliese, E. Billaud, and I. Poizot-martin, Real life evaluation of HIV-1 infected patients treated with an ARV combination therapy including raltegravir in France the final RACING study results (M24) 14th European AIDS Conference, 2013.

A. C. Justice, W. Holmes, and A. L. Gifford, Development and validation of a self-completed HIV symptom index, J Clin Epidemiol, vol.54, issue.12, pp.77-90, 2001.

J. D. Fisk, P. G. Ritvo, and L. Ross, Measuring the functional impact of fatigue: initial validation of the fatigue impact scale, Clin Infect Dis, vol.18, issue.1, pp.79-83, 1994.

B. W. Pence, J. Barroso, J. L. Harmon, J. Leserman, N. Salahuddin et al., Chronicity and remission of fatigue in patients with established HIV infection, AIDS Patient Care STDs, vol.23, issue.4, pp.239-244, 2009.

E. J. Edelman, K. Gordon, M. C. Rodriguez-barradas, and A. C. Justice, Patient-Reported symptoms on the antiretroviral regimen efavirenz/ emtricitabine/tenofovir, AIDS Patient Care STDs, vol.26, issue.6, pp.312-319, 2012.
DOI : 10.1089/apc.2012.0044

URL : http://europepmc.org/articles/pmc3412583?pdf=render

. Spire, Quality of life in HIV-1 patients treated with raltegravir
URL : https://hal.archives-ouvertes.fr/inserm-01986117

J. G. Voss, Predictors and correlates of fatigue in HIV/AIDS, J Pain Symptom Manage, vol.29, issue.2, pp.173-184, 2005.

M. Préau, F. Marcellin, M. P. Carrieri, F. Lert, Y. Obadia et al., Health-related quality of life in French people living with HIV in 2003: results from the national ANRS-EN12-VESPA Study, AIDS, vol.21, issue.1, pp.19-27, 2007.

S. B. Rourke, T. Bekele, and R. Tucker, Housing characteristics and their influence on health-related quality of life in persons living with HIV in Ontario, Canada: results from the positive spaces, healthy places study, AIDS Behav, vol.16, issue.8, pp.2361-2373, 2012.

G. M. Louwagie, M. O. Bachmann, K. Meyer, B. Fle, R. Fairall et al., Highly active antiretroviral treatment and health related quality of life in South African adults with human immunodeficiency virus infection: a cross-sectional analytical study, BMC Public Health, vol.7, p.682, 2007.

A. Bader, H. Kremer, and I. Erlich-trungenberger, An adherence typology: coping, quality of life, and physical symptoms of people living with HIV/AIDS and their adherence to antiretroviral treatment, Med Sci Monit, vol.12, issue.12, pp.493-500, 2006.

G. Guaraldi, R. Murri, and G. Orlando, Lipodystrophy and quality of life of HIV-infected persons, AIDS Rev, vol.10, issue.3, pp.152-161, 2008.

Z. Liu, J. Yang, H. Liu, and J. Y. , Factors associated with fatigue in acquired immunodeficiency syndrome patients with antiretroviral drug adverse reactions: a retrospective study, J Tradit Chin Med, vol.33, issue.3, pp.316-321, 2013.
DOI : 10.1016/s0254-6272(13)60172-7

URL : https://doi.org/10.1016/s0254-6272(13)60172-7

C. Gay, C. J. Portillo, and R. Kelly, Self-reported medication adherence and symptom experience in adults With HIV, J Assoc Nurses AIDS Care, vol.22, issue.4, pp.257-268, 2011.
DOI : 10.1016/j.jana.2010.11.004

URL : http://europepmc.org/articles/pmc3117946?pdf=render

M. Battegay and L. Elzi, Morbidity and mortality in HIV-infected individuals-a shift towards comorbidities, Swiss Med Wkly, vol.139, pp.564-570, 2009.

C. Protopopescu, F. Marcellin, and B. Spire, Health-related quality of life in HIV-1-infected patients on HAART: a five-years longitudinal analysis accounting for dropout in the APROCO-COPILOTE cohort (ANRS CO-8), Qual Life Res, vol.16, issue.4, pp.577-591, 2007.